Dr Stephen Luen is a Medical Oncologist and translational researcher at the Peter MacCallum Cancer Centre. His current research interests include the study of genomic and immune biomarkers in breast cancer, with a particular focus on investigating biological characteristics and developing clinical trials for high-risk subgroups of patients.

We spoke to Dr Luen about the role of genomic testing in breast cancer treatment.